BARINTHUS BIOTHERAPEUTICS PL (BRNS) Institutional Ownership Changes & 13F Activity
BARINTHUS BIOTHERAPEUTICS PL (BRNS). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Renaissance Technologies LLC, Morgan Stanley, Gts Securities Llc, Citadel Advisors Llc, and Hightower Advisors, Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Sell | -42,242 | -35.5% | 76,754 | $50.66K | Q2 2026 | Sep 02, 2026 |
| Rangeley Capital, Llc | Buy | +25,671 | +16.1% | 185,136 | $122.19K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +14,819 | — | 14,819 | $9.78K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Securities, Llc | Buy | +11,052 | — | 11,052 | $7.29K | Q2 2026 | Aug 14, 2026 |
| Renaissance Technologies LLC | Sell | -126,000 | -83.4% | 25,000 | $16.50K | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Buy | +106,633 | +4825.0% | 108,843 | $71.84K | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Buy | +1,008 | — | 1,008 | $665.00 | Q2 2026 | Aug 13, 2026 |
| Gts Securities Llc | Sell | -73,210 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Geode Capital Management, Llc | Sell | -11,568 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Hightower Advisors, Llc | Sell | -37,450 | -100.0% | 0 | $0.00 | Q2 2026 | May 05, 2026 |
Frequently asked questions about BRNS activity
Which institutional owners are buying BRNS?
Institutional owners buying BRNS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in BRNS activity?
"Buy" means an investor increased their reported position in BRNS compared to the prior reporting period. This reflects growing exposure to BARINTHUS BIOTHERAPEUTICS PL (BRNS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in BRNS increasing?
Institutional interest in BRNS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related BRNS Institutional Insights
- BRNS Overview
- BRNS 13F Institutional Holders
- BRNS Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- BRNS Insider Trading & SEC Form 4 Activity
- BRNS Articles
- Top Institutional Investor Stock Rankings